"For over 60 years, residents in the Northland and surrounding communities have trusted North Kansas City Hospital with their healthcare. Every day, more than 3,000 employees and over 500 physicians handle emergencies, deliver babies, treat cancers, heal hearts, rejuvenate joints, and promote health and wellness. NKCH is a Magnet hospital, meaning it has earned the highest achievement for nursing excellence. Meritas Health, the hospital's wholly-owned subsidiary, offers the largest network of physician practices in the Northland. Together, NKCH and MH serve the community through 35 convenient locations, including a 451-licensed-bed facility, express and urgent care clinics, and several primary and specialty care clinics."

During the past decade, North Kansas City Hospital conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 93 clinical trials were completed, i.e. on average, 404.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 33 clinical trials were completed. i.e. 412.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North Kansas City Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 52 trials, followed by "SWOG Cancer Research Network" with 25 trials sponsored, "Alliance for Clinical Trials in Oncology" with 24 trials sponsored, "Radiation Therapy Oncology Group" with 8 trials sponsored and "Gynecologic Oncology Group" with 8 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Kansas City Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 85 trials as a collaborator, "NRG Oncology" with 19 trials as a collaborator, "NCIC Clinical Trials Group" with 8 trials as a collaborator, "SWOG Cancer Research Network" with 8 trials as a collaborator and "Cancer and Leukemia Group B" with 7 trials as a collaborator. Other collaborators include 44 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "North Kansas City Hospital" are "Breast Cancer" (13 trials), "Lung Cancer" (9 trials), "Colorectal Cancer" (8 trials), "Leukemia" (8 trials) and "Lymphoma" (8 trials). Many other conditions were trialed in "North Kansas City Hospital" in a lesser frequency.

Most popular intervention types in "North Kansas City Hospital" are "Drug" (111 trials), "Other" (77 trials), "Biological" (46 trials), "Radiation" (29 trials) and "Procedure" (18 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (42 trials), "Quality-of-Life Assessment" (19 trials), "Paclitaxel" (16 trials), "Bevacizumab" (15 trials) and "Carboplatin" (13 trials). Other intervention names were less common.

The vast majority of trials in "North Kansas City Hospital" are 115 trials for "All" genders, 35 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "North Kansas City Hospital". undefined are not yet recruiting, 5 are recruiting, 55 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 84 completed trials in North Kansas City Hospital, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in North Kansas City Hospital, 5 "Phase 1" clinical trials were conducted, 49 "Phase 2" clinical trials and 75 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 7 trials that are defined as “Not Applicable".

North Kansas City Hospital has several departments that took part in Clinical trials: "Radiation Oncology Associates of Kansas City at Northland Radiation Oncology Center" - 5 trials, "Kansas City Vascular" - 2 trials